Literature DB >> 1451726

Dose-dependent kinetics of the enantiomers of MK-571, and LTD4-receptor antagonist.

M Depré1, D J Margolskee, A Van Hecken, J S Hsieh, A Buntinx, P J De Schepper, J D Rogers.   

Abstract

The disposition of the enantiomers of MK-571 (MK-0679 and L-668,018) following single i.v. doses of MK-571 (L-660,711) was studied in a three way cross-over study in 12 healthy male volunteers. Each volunteer received 75 mg, 300 mg and 600 mg i.v. doses of MK-571 at weekly intervals. The disposition of both enantiomers appeared dose-dependent, since the AUC increased disproportionately faster than the dose. The dose dependency was much more pronounced for L-668,018: its AUC increased 6-fold from the 75 to the 300 mg dose, 16-fold from 75 to 600 mg and 2.7 fold from 300 to 600 mg. For MK-0679, the corresponding increases in AUC were 4.8-, 11-, and 2.3 fold. Regardless of dose, the elimination of L-668,018 was more rapid than that of MK-0679. The disposition of MK-0679 needs to be investigated independently to detect any potential influence of L-668,018 on its disposition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451726     DOI: 10.1007/bf02220622

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  5 in total

Review 1.  Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.

Authors:  D J Margolskee
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.

Authors:  P J Manning; R M Watson; D J Margolskee; V C Williams; J I Schwartz; P M O'Byrne
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

3.  Stereoselective determination of R(-)- and S(+)-MK-571, a leukotriene D4 antagonist, in human plasma by chiral high-performance liquid chromatography.

Authors:  R S Robinett; J Y Hsieh
Journal:  J Chromatogr       Date:  1991-09-18

4.  Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man.

Authors:  M Depré; D J Margolskee; J Y Hsieh; A Van Hecken; A Buntinx; I De Lepeleire; J D Rogers; P J De Schepper
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.

Authors:  J C Kips; G F Joos; I De Lepeleire; D J Margolskee; A Buntinx; R A Pauwels; M E Van der Straeten
Journal:  Am Rev Respir Dis       Date:  1991-09
  5 in total
  1 in total

1.  Oral pharmacokinetics and food interaction of the leukotriene D4 receptor antagonist verlukast.

Authors:  J I Schwartz; D J Margolskee; T D Bjornsson; V C Williams; J Y Hsieh; C C Lin; J D Rogers
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.